Jared Holz
Jared Holz is a financial analyst at Mizuho Securities, known for his expertise in the pharmaceutical sector. Recently, he commented on Pfizer's struggles to excite investors due to a lack of promising new products in its pipeline and the company's ongoing efforts to manage costs amidst declining sales, particularly in the wake of diminishing demand for COVID-19 related treatments.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Jared Holz, an analyst with Mizuho, said in a note to clients that the actual comment from the President is direct but its impact may be somewhere between nebulous and negligible.
5
Ireland:
Mizuho Securities healthcare specialist Jared Holz commented on the potential impact of the tariffs.
5
Ireland:
Mizuho analyst Jared Holz stated that investors are just not excited about the current Pfizer business or the pipeline.
4